These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35349243)

  • 21. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
    Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
    Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.
    Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B
    Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More bad news for cardiac resynchronization therapy in atrial fibrillation patients: what to do?
    Holmqvist F; Daubert JP
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1123-4. PubMed ID: 24015991
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients' apps combined with remote monitoring?
    Sgreccia D; Mauro E; Vitolo M; Manicardi M; Valenti AC; Imberti JF; Ziacchi M; Boriani G
    Expert Rev Med Devices; 2022 Feb; 19(2):155-160. PubMed ID: 35129023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator.
    Tajstra M; Sokal A; Gadula-Gacek E; Kurek A; Wozniak A; Niedziela J; Adamowicz-Czoch E; Rozentryt P; Milewski K; Jachec W; Kalarus Z; Poloński L; Gasior M
    Europace; 2020 May; 22(5):769-776. PubMed ID: 32304216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.
    Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
    Steffen MM; Osborn JS; Cutler MJ
    Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projected longevities of cardiac implantable defibrillators: a retrospective analysis over the period 2007-17 and the impact of technological factors in determining longevity.
    Paton MF; Landolina M; Billuart JR; Field D; Sibley J; Witte K
    Europace; 2020 Jan; 22(1):149-155. PubMed ID: 31407793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure.
    Manlucu J; Sharma V; Koehler J; Warman EN; Wells GA; Gula LJ; Yee R; Tang AS
    J Am Heart Assoc; 2019 Jul; 8(14):e010998. PubMed ID: 31291801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
    Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current attitudes on cardiac devices in heart failure: a review.
    Marangou J; Paul V
    Clin Ther; 2015 Oct; 37(10):2206-14. PubMed ID: 26386500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting.
    Laish-Farkash A; Bruoha S; Katz A; Goldenberg I; Suleiman M; Michowitz Y; Shlomo N; Einhorn-Cohen M; Khalameizer V
    Europace; 2017 Aug; 19(8):1357-1363. PubMed ID: 27733457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remote Monitoring for Chronic Disease Management: Atrial Fibrillation and Heart Failure.
    Ono M; Varma N
    Card Electrophysiol Clin; 2018 Mar; 10(1):43-58. PubMed ID: 29428141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marital Status and Long-Term Outcomes in Mild Heart Failure Patients With an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator.
    Goldenberg M; Aktas MK; Younis A; Zareba W; McNitt S; Kutyifa V
    Am J Cardiol; 2020 Apr; 125(8):1180-1186. PubMed ID: 32088000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.